FDA Clearance Tracker · P150011-S028
Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve
Last checked: Nov 20, 2026Latest source record: Mar 12, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 12, 2025
Approved
Time to decision
237 days
Received Jul 18, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P150011-S028
- Device name
- Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve
- Applicant
- Corcym S.r.l.
- Applicant location
- Saluggia
- Received
- Jul 18, 2024
- Decided
- Mar 12, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150011
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for the following manufacturing site: Corcym S.r.l, Via Crescentino sn, 13040 Saluggia (VC) ITALY, Operations to be performed: manufacturing, packaging, sterilization
Source documents
Other decisions for Corcym S.r.l.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261707 · Decided Jun 18, 2026 · 27 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.